Use of eicosapentaenoic acid (epa), docosaexaenoic acid (dha) or a mixture of epa and dha or a pharmaceutically acceptable salt or derivative thereof

摘要

"Use of Eicosapentaenoic Acid (EPA), DOCOSAEXAenoic Acid (DHA) or a Mixture of EPA and DHA or a Pharmaceutically Acceptable Salt or Derivative". The invention is directed to the use of n-3 PUFA EPA and / or DRA in the preparation of an oral medicament to prevent brain damage in patients having symptoms of atherosclerosis of brain-supplying arteries.